IL81809A - Method and compositions for increasing mammary parenchyma - Google Patents

Method and compositions for increasing mammary parenchyma

Info

Publication number
IL81809A
IL81809A IL81809A IL8180987A IL81809A IL 81809 A IL81809 A IL 81809A IL 81809 A IL81809 A IL 81809A IL 8180987 A IL8180987 A IL 8180987A IL 81809 A IL81809 A IL 81809A
Authority
IL
Israel
Prior art keywords
mammal
compositions
mammary parenchyma
parenchyma
increasing
Prior art date
Application number
IL81809A
Other languages
English (en)
Other versions
IL81809A0 (en
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of IL81809A0 publication Critical patent/IL81809A0/xx
Publication of IL81809A publication Critical patent/IL81809A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catching Or Destruction (AREA)
  • Mushroom Cultivation (AREA)
  • Liquid Deposition Of Substances Of Which Semiconductor Devices Are Composed (AREA)
IL81809A 1986-03-07 1987-03-06 Method and compositions for increasing mammary parenchyma IL81809A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83747786A 1986-03-07 1986-03-07

Publications (2)

Publication Number Publication Date
IL81809A0 IL81809A0 (en) 1987-10-20
IL81809A true IL81809A (en) 1993-01-31

Family

ID=25274560

Family Applications (1)

Application Number Title Priority Date Filing Date
IL81809A IL81809A (en) 1986-03-07 1987-03-06 Method and compositions for increasing mammary parenchyma

Country Status (22)

Country Link
US (1) US5059586A (cs)
EP (1) EP0237514B1 (cs)
JP (1) JPS62221635A (cs)
KR (1) KR900000545B1 (cs)
CN (1) CN87102601A (cs)
AT (1) ATE93730T1 (cs)
AU (1) AU595295B2 (cs)
BG (1) BG50926A3 (cs)
CA (1) CA1299103C (cs)
CS (1) CS272772B2 (cs)
DD (1) DD258943A5 (cs)
DE (1) DE3787185T2 (cs)
DK (1) DK116287A (cs)
ES (1) ES2000437T3 (cs)
HU (1) HU205007B (cs)
IL (1) IL81809A (cs)
MX (1) MX170911B (cs)
NO (1) NO870946L (cs)
NZ (1) NZ219530A (cs)
PL (1) PL154182B1 (cs)
RU (1) RU2033178C1 (cs)
ZA (1) ZA871654B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130300A (en) * 1986-03-07 1992-07-14 Monsanto Company Method for enhancing growth of mammary parenchyma
US5130299A (en) * 1986-03-07 1992-07-14 Monsanto Company Method for enhancing growth of mammary parenchyma
US5182302A (en) * 1986-03-07 1993-01-26 Monsanto Company Method for enhancing growth of mammary parenchyma using a prostaglandin
IE912345A1 (en) * 1990-08-03 1992-02-12 Pharmacia Ab Treatment of human lactation failure
US5336488A (en) * 1991-08-07 1994-08-09 American Cyanamid Company Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines
US6828111B2 (en) 2000-01-13 2004-12-07 Wayne State University Three-dimensional in vitro model of human preneoplastic breast disease
RU2185198C2 (ru) * 2000-05-15 2002-07-20 Российский Университет Дружбы Народов Способ лечения кисты молочной железы
NZ529806A (en) * 2001-05-18 2005-08-26 Ca Minister Agriculture & Food Nucleic acid and protein sequences of bovine epidermal growth factor
JP2017046688A (ja) * 2015-08-31 2017-03-09 株式会社みやぎヘルスイノベーション 体重増加抑制用飲料組成物
CN105194642B (zh) * 2015-10-09 2018-04-17 深圳市容大生物技术有限公司 一种疏通乳房微循环养护自体腺胞的组合物及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011312A (en) * 1975-06-25 1977-03-08 American Home Products Corporation Prolonged release drug form for the treatment of bovine mastitis
EP0085036A1 (en) * 1982-01-18 1983-08-03 Monsanto Company Method for improved bovine milk production
US4521409A (en) * 1983-10-03 1985-06-04 Cornell Research Foundation, Inc. Use of growth hormone to enhance ruminant mammary development

Also Published As

Publication number Publication date
JPS62221635A (ja) 1987-09-29
ATE93730T1 (de) 1993-09-15
US5059586A (en) 1991-10-22
ZA871654B (en) 1987-08-28
DK116287A (da) 1987-09-08
HUT47031A (en) 1989-01-30
DE3787185T2 (de) 1994-02-03
CN87102601A (zh) 1987-12-16
EP0237514A1 (en) 1987-09-16
DD258943A5 (de) 1988-08-10
HU205007B (en) 1992-03-30
NO870946D0 (no) 1987-03-06
BG50926A3 (bg) 1992-12-15
KR880010773A (ko) 1988-10-24
AU6978887A (en) 1987-09-10
ES2000437T3 (es) 1994-01-16
KR900000545B1 (ko) 1990-01-31
PL264490A1 (en) 1988-02-18
CS151887A2 (en) 1990-06-13
NZ219530A (en) 1992-12-23
AU595295B2 (en) 1990-03-29
PL154182B1 (en) 1991-07-31
DE3787185D1 (de) 1993-10-07
CS272772B2 (en) 1991-02-12
NO870946L (no) 1987-09-08
DK116287D0 (da) 1987-03-06
ES2000437A4 (es) 1988-03-01
RU2033178C1 (ru) 1995-04-20
EP0237514B1 (en) 1993-09-01
MX170911B (es) 1993-09-22
IL81809A0 (en) 1987-10-20
CA1299103C (en) 1992-04-21

Similar Documents

Publication Publication Date Title
DE69008476D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose.
CS274681B2 (en) Method of erythropoietin's stabilized preparation production
DK246589D0 (da) Stabiliseret fibroblast-vaekstfaktor-praeparat og f remgangsmaade til fremstilling deraf
HUT42329A (en) Process for producing compositions for curing wounds
IL82209A0 (en) Insulin preparation
CA2058443A1 (en) Treating Disorders by Application of Insulin-Like Growth Factors and Analogs
ES8507567A1 (es) Metodo para estabilizar un concentrado de gamma globulina
ZA871654B (en) Method and compositions for increasing mammary parenchyma
NO940180L (no) Anvendelse av IGF-I
ES460743A1 (es) Procedimiento para la obtencion de preparados medicinales con ph acido.
ATE54824T1 (de) System zur arzneistoffabgabe mit erhoehter bioakzeptanz.
ATE17651T1 (de) Mischung zum verabreichen bei menschen von selenium als spurenelement.
SE8400723D0 (sv) Farmaceutisk komposition
DE3370762D1 (en) Compositions for use in increasing brain tyrosine levels
IT8748116A0 (it) Derivati di glicina in qualita' di agenti preventivi e terapeutici del le complicanze diabetiche
AU566250B2 (en) Syringe in which needle connects to plunger
DE69231583D1 (de) Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält.
DE3476736D1 (en) Use of an antihypoxidoticum with cerebral and peripheral effect
AU8269987A (en) Synergistic treatment method
Smirnova Effect of histamine and prostaglandins E2 and F2 alpha on the electrical activity of stomach cells in the rat
廖玎玲 et al. INFLUENCE OF “ARTIFICIAL CYCLE BY TRADITIONAL CHINESE MEDICINE” ON THE FUNCTION OF FEMALE GONADS
JO1445B1 (en) Liquid formulations to increase agricultural crops production
BE748773R (en) Herbicide for use in beet crops
IT211409Z2 (it) Bocchetta per infissi,con invito conico per assicurare l'inserimento del chiavistello e per determinare il forzamento in chiusura.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees